The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_001100.4(ACTA1):c.217dup (p.Ile73fs)

CA915942047

817462 (ClinVar)

Gene: ACTA1
Condition: alpha-actinopathy
Inheritance Mode: Autosomal recessive inheritance
UUID: e3f9ec67-adea-4393-8423-5bcc29d619bd
Approved on: 2024-08-07
Published on: 2024-12-19

HGVS expressions

NM_001100.4:c.217dup
NM_001100.4(ACTA1):c.217dup (p.Ile73fs)
NC_000001.11:g.229432793dup
CM000663.2:g.229432793dup
NC_000001.10:g.229568540dup
CM000663.1:g.229568540dup
NC_000001.9:g.227635163dup
NG_006672.1:g.6304dup
ENST00000366683.4:c.217dup
ENST00000684723.1:c.82dup
ENST00000366683.3:c.217dup
ENST00000366684.7:c.217dup
NM_001100.3:c.217dup
More

Pathogenic

Met criteria codes 3
PM2_Supporting PM3 PVS1
Not Met criteria codes 1
PS4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Congenital Myopathies Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for ACTA1 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Congenital Myopathies VCEP
The NM_001100.4:c.217dup (p.Ile73fs*11) variant in ACTA1 is a frameshift variant that is expected to result in nonsense-mediated mRNA decay and is present in biologically-relevant transcripts (PVS1). The variant is absent from gnomAD v4.1.0 (PM2_Supporting). There is no published data on this variant, however Invitae has reported the variant in one proband, who presented with hypotonia (SCV001201868.3). In addition, this proband carried the variant of interest in trans with a second ACTA1 variant c.782A>T (p.Glu261Val) that has been classified as pathogenic at Invitae (PM3). In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive alpha-actinopathy. ACMG/AMP criteria met, as specified by the congenital myopathies VCEP: PVS1, PM2_Supporting, PM3 (ClinGen Congenital Myopathies VCEP specifications version 1; 08/07/2024).
Met criteria codes
PM2_Supporting
The variant is absent from gnomAD v4.1.0 with adequate genome and exome coverage, meeting PM2_Supporting criteria.
PM3
The proband carried the variant of interest in trans with a second ACTA1 variant c.782A>T (p.Glu261Val) that has been classified as pathogenic at Invitae.
PVS1
The variant is a frameshift variant that is predicted to undergo nonsense-mediated mRNA decay and is present in biologically-relevant transcripts
Not Met criteria codes
PS4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.